AtriCure Reports First Quarter 2008 Financi...( High...)

Highlights

- Record consolidated revenues of $13.5 million - up 26% over 2007 - Record revenues from minimally invasive products - $4.9 million - up 65% - Record number of minimally invasive procedures performed in 92 U.S.

centers - Release of Coolrail(TM) linear ablation device and ORLab(TM) mapping

system

WEST CHESTER, Ohio, May 6 /PRNewswire-FirstCall/ -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced record first quarter 2008 revenues of $13.5 million and record revenues from minimally invasive products of $4.9 million, a 65.3% increase over the first quarter of 2007.

"We are pleased with our first quarter financial results. Adoption of our minimally invasive platform is growing rapidly, evidenced by increased physician adoption and a record 92 U.S. medical centers performing procedures during the first quarter. Minimally invasive results for the quarter confirm the power of our strategy and our capacity to quickly develop and commercialize innovative cardiac ablation systems," said David Drachman, President and Chief Executive Officer. "Moving forward, we believe that our recently released Coolrail(TM) linear ablation device and ORLab(TM) mapping system, when used with our other leading minimally invasive products, will accelerate the adoption and growth of our minimally invasive business."

First Quarter 2008 Financial Results

Revenues for the first quarter of 2008 were a record $13.5 million, a 25.9% increase over the first quarter of 2007 and a sequential increase of 2.9% over the fourth quarter of 2007. Revenues fr
'/>"/>